Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, Adriana Yndart, Madhavan NairDepartment of Immunology and Nano-Medicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USAAbstract: Currently, 47 million people live with d...
Guardado en:
Autores principales: | Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b72cb3da3be4fc29617398ad923244b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020) -
Long noncoding RNAs and Alzheimer's disease
por: Luo Q, et al.
Publicado: (2016) -
Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Guimei Zhang, et al.
Publicado: (2021) -
Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
por: Bagyinszky E, et al.
Publicado: (2016) -
Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013)